The Growing Case for Use of SGLT2i in Heart Failure: Additional Benefits of Empagliflozin in a HFpEF Rodent Model

[Figure: see text]

Detalles Bibliográficos
Autores principales: Ha, Chae-Myeong, Wende, Adam R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Editorial Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390674/
https://www.ncbi.nlm.nih.gov/pubmed/30847417
http://dx.doi.org/10.1016/j.jacbts.2019.01.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390674/
https://www.ncbi.nlm.nih.gov/pubmed/30847417
http://dx.doi.org/10.1016/j.jacbts.2019.01.003

Ejemplares similares